N-6022

DB12206InvestigationalSmall molecule

N6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.

Chemical structure of N-6022
Mechanism
Curator reviewed
Formula / weight
C24H22N4O3 · 414.4565 g/mol (avg)
Code names
N6022

Resolves to

Compound
UNII80LIU5P95DCAS1208315-24-5ChEMBLCHEMBL1738699PubChem44623946
Structure
InChIKeyYVPGZQLRPAGKLA-UHFFFAOYSA-NSMILESCC1=CC(=CC=C1N1C(CCC(O)=O)=CC=C1C1=CC=C(C=C1)N1C=CN=C1)C(N)=O
Targets
P11766ADH5P16152CBR1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with N-6022, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In